Literature DB >> 8618712

Inpatient costs of specific cerebrovascular events at five academic medical centers.

R G Holloway1, D M Witter, K B Lawton, J Lipscomb, G Samsa.   

Abstract

We estimated the hospital costs for patients with different cerebrovascular events and applied patient and administrative variables to explain the variance of the cost estimates with particular attention to the relationship between patient age and cost. The study sample was drawn from an administrative data set of all hospital discharges from five academic medical centers for the 1992 calendar year. Using International Classification of Diseases (ICD-9-CM) primary diagnosis codes, cases were classified into cerebrovascular subgroups: subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), ischemic cerebral infarction (ICI), and transient ischemic attack (TIA). The ICD-9-driven data file was supplemented with billing data containing inpatient charges reported in UB-82 format. Costs were imputed by applying Medicare charge-to-cost ratios and regional wage adjustments to the billing data. We estimated relationships between inpatient costs and a number of demographic and administrative variables. A statistically significant difference was found between cerebrovascular subgroups for both the mean cost per discharge (p<0.01) and the mean cost of an inpatient day (p<0.01). The mean cost per discharge for each subgroup was as follows: SAH, $39,994 (n=218); ICH, $21,535 (n=258); ICI, $9,882 (n=908); TIA, $4,653 (n=303). Likewise, the mean cost per inpatient day was as follows: SAH, $2,215; ICH, $1,396; ICI, $1,036; TIA, $1,117. Length of stay as a measure of resource use was strongly predictive of inpatient cost, explaining 72 to 82% of the variation in cost. Demographic variables (i.e., age, gender, race, insurance status), however, revealed virtually no predictive power, accounting for less than 10% of the variance in each of the four subgroups. There are substantial differences in the patient-level cost of hospital services for stroke-related events. After controlling for the type of cerebrovascular event, basic demographic variables and insurance status (including Medicare) contribute little to the total cost of inpatient care. More important factor include stroke severity, social factors, and clinical practice variations.

Entities:  

Mesh:

Year:  1996        PMID: 8618712

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.

Authors:  J E Lafata; S A Martin; S Kaatz; R E Ward
Journal:  J Gen Intern Med       Date:  2000-01       Impact factor: 5.128

2.  Can demographic and admission laboratory variables be useful to identify long-stay patients with acute ischemic stroke? A hospital-based cohort study in Singapore.

Authors:  Raymond C S Seet; Erle C H Lim; Y H Chan; Bernard P L Chan; Amy M L Quek; Benjamin K C Ong
Journal:  Neurol Sci       Date:  2009-04-22       Impact factor: 3.307

3.  Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients.

Authors:  Yi Li; Han-xu Xi; Sha Zhu; Na Yu; Jing Wang; Yan Li; Guo-pei Yu; Xie-min Ma; Jun Zhang; Lue-ping Zhao
Journal:  Chin J Integr Med       Date:  2014-08-05       Impact factor: 1.978

4.  Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation.

Authors:  Jonathan Karnon; Jackie Brown
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

5.  Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation.

Authors:  Hooman Kamel; J Donald Easton; S Claiborne Johnston; Anthony S Kim
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

6.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

7.  Design of the economic evaluation for the Interventional Management of Stroke (III) trial.

Authors:  Patrick D Mauldin; Kit N Simpson; Yuko Y Palesch; Judy S Spilker; Michael D Hill; Pooja Khatri; Joseph P Broderick
Journal:  Int J Stroke       Date:  2008-05       Impact factor: 5.266

Review 8.  The medical economics of stroke.

Authors:  T N Taylor
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 9.  Management of patients with acute ischaemic stroke.

Authors:  H P Adams
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 10.  Clinical review: Critical care management of spontaneous intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.